BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34825570)

  • 1. Does the publication of NICE guidelines for venous thromboembolism chemical prophylaxis influence the prescribing patterns of UK hip and knee surgeons?
    Matharu GS; Blom AW; Board T; Whitehouse MR;
    Ann R Coll Surg Engl; 2022 Mar; 104(3):195-201. PubMed ID: 34825570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes in preferences for venous thromboembolism prophylaxis after total joint arthroplasty in Turkey: A survey.
    Azboy N; Çimen O; Demirtaş A; Elçi S; Azboy İ
    Eklem Hastalik Cerrahisi; 2018 Dec; 29(3):139-46. PubMed ID: 30376797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.
    Blin P; Samama CM; Sautet A; Benichou J; Lignot-Maleyran S; Lamarque S; Lorrain S; Lassalle R; Droz-Perroteau C; Mismetti P; Moore N
    Pharmacol Res; 2019 Mar; 141():201-207. PubMed ID: 30583081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in pharmacologic prophylaxis for venous thromboembolism after hip and knee replacement in older adults.
    Ko D; Kapoor A; Rose AJ; Hanchate AD; Miller D; Winter MR; Palmisano JN; Henault LE; Fredman L; Walkey AJ; Tripodis Y; Karcz A; Hylek EM
    Vasc Med; 2020 Oct; 25(5):450-459. PubMed ID: 32516054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement.
    Salazar CA; Malaga G; Malasquez G
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD005981. PubMed ID: 20393944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does venous thromboembolism prophylaxis affect the risk of venous thromboembolism and adverse events following primary hip and knee replacement? A retrospective cohort study.
    Todd F; Yeomans D; Whitehouse MR; Matharu GS
    J Orthop; 2021; 25():301-304. PubMed ID: 34140759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
    Kapoor A; Chuang W; Radhakrishnan N; Smith KJ; Berlowitz D; Segal JB; Katz JN; Losina E
    Pharmacoeconomics; 2010; 28(7):521-38. PubMed ID: 20550220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis.
    Veettil SK; Harris J; Syeed MS; Thakkinstian A; Chaikledkaew U; Witt DM; Chaiyakunapruk N
    Thromb Res; 2022 Aug; 216():74-83. PubMed ID: 35753113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
    Mahmoudi M; Sobieraj DM
    Pharmacotherapy; 2013 Dec; 33(12):1333-40. PubMed ID: 23625693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis.
    Kapoor A; Ellis A; Shaffer N; Gurwitz J; Chandramohan A; Saulino J; Ishak A; Okubanjo T; Michota F; Hylek E; Trikalinos TA
    J Thromb Haemost; 2017 Feb; 15(2):284-294. PubMed ID: 28102615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017.
    Mirkazemi C; Bereznicki LR; Peterson GM
    BMC Musculoskelet Disord; 2019 Feb; 20(1):57. PubMed ID: 30736774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
    Hovik O; Amlie EJ; Jenssen KK
    J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism after total knee replacement or total hip replacement: what can be learnt from root-cause analysis?
    Benjamin S; Warwick D
    Ann R Coll Surg Engl; 2016 Nov; 98(8):538-542. PubMed ID: 27513792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.